ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
3.200
+1.170 (57.64%)
At close: Aug 13, 2025, 4:00 PM
3.210
+0.010 (0.31%)
Pre-market: Aug 14, 2025, 9:21 AM EDT
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$398,611
Profits / Employee
-$192,389
Market Cap
7.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RSLS News
- 21 hours ago - Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - Business Wire
- 1 day ago - Vyome Announces New Board of Directors with Deep MIT and AI Ties - Business Wire
- 6 days ago - ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire
- 20 days ago - ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 23 days ago - ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewsWire
- 23 days ago - ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewsWire
- 6 weeks ago - ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - GlobeNewsWire
- 6 weeks ago - ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - GlobeNewsWire